Member Since 2022
Jo Bhakdi is the Founder and CEO of Quantgene with the mission to extend the healthy human life span by a decade within a decade. Together with Quantgene’s team of scientists and engineers, he is dedicated to introducing cloud, AI and precision diagnostics into the standard of care to enhance quality and accessibility of care for everyone and protect human life. Born to scientist parents, Jo grew up with a backdrop of medical research before earning a Master’s in Economics from Tubingen University, one of Germany’s leading academic institutions. Prior to Quantgene, Jo held executive positions at BDDO and Omnicom with a focus on business model innovation and technology, then founded i2X, an investment platform that provides quantitative analytics for biotechnology and technology portfolios.
Quantgene was founded in 2015 at UC Berkeley with the mission to detect cancer and other diseases early and protect human life. Now based in Santa Monica, CA, with offices in Portland and Berlin, Quantgene has galvanized a team of scientists and technologists to push the boundaries of precision and preventive medicine. With the backbone of a world-leading laboratory infrastructure and AI-powered cloud system, Quantgene has utilized its talent and technology to transform healthcare through three business units: Apollo, Pandemic Protect, and Serenity. Apollo deploys the world’s most advanced medical intelligence system to close the care gap in precision preventive medicine and chronic care management for providers and large systems. Pandemic Protect has kept Hollywood’s entertainment industry in business and has partnered with government agencies coast-to-coast, keeping US citizens safe. Using superior data and intelligence to detect genetic and real-time medical risks, Serenity aims to extend the healthy human lifespan by a decade within a decade.